Lactation stage influences drug milk-to-serum values and neonatal exposure risk

B Ling, J Alcorn - International journal of toxicology, 2010 - journals.sagepub.com
The purpose of our study was to assess the influence of lactation stage–dependent
differences in milk-to-serum (M/S) ratio for an actively transported drug (cefepime) on the …

[PDF][PDF] Physiologically-based pharmacokinetic modelling of infant exposure to efavirenz through breastfeeding

A Olagunju, RKR Rajoli… - AAS Open …, 2018 - aasopenresearch.s3.amazonaws …
Background: Very little is known about the level of infant exposure to many drugs commonly
used during breastfeeding. The aim of this study was to develop a physiologically-based …

Methodological approaches to evaluate fetal drug exposure

N Bouazza, F Foissac, D Hirt, S Urien… - Current …, 2019 - ingentaconnect.com
Background: Drug prescriptions are usual during pregnancy, however, women and their
fetuses still remain an orphan population with regard to drugs efficacy and safety. Most …

Using pharmacokinetics to predict the effects of pregnancy and maternal–infant transfer of drugs during lactation

GD Anderson - Expert opinion on drug metabolism & toxicology, 2006 - Taylor & Francis
Knowledge of pharmacokinetics and the use of a mechanistic-based approach can improve
our ability to predict the effects of pregnancy for medications when data are limited. Despite …

Fetal physiologically based pharmacokinetic models: systems information on fetal blood components and binding proteins

K Abduljalil, M Jamei, TN Johnson - Clinical Pharmacokinetics, 2020 - Springer
Background Fetal blood and plasma volume and binding components are critical
parameters in a fetal physiologically based pharmacokinetic model. To date, a …

Neonatal exposure to drugs in breast milk

PJ McNamara, M Abbassi - Pharmaceutical research, 2004 - Springer
There are many benefits of breast-feeding both for the infant and for the mother. Nursing
mothers who are also taking medications or exposed to environmental hazards may be …

European study for neonatal excipient exposure (ESNEE)

MA Turner, T Storme - European Journal of Hospital Pharmacy, 2012 - ejhp.bmj.com
Excipients are frequently used to facilitate the manufacture and storage of medicines.
Pharmacological effects and adverse events can be attributed to excipients. Examples in …

Assessing the impacts on fetal dosimetry of the modelling of the placental transfers of xenobiotics in a pregnancy physiologically based pharmacokinetic model

M Codaccioni, C Brochot - Toxicology and Applied Pharmacology, 2020 - Elsevier
The developmental origin of health and diseases theory supports the critical role of the fetal
exposure to children's health. We developed a physiologically based pharmacokinetic …

Evaluation of the potential impact of pharmacokinetic differences on tissue dosimetry in offspring during pregnancy and lactation

PR Gentry, TR Covington, HJ Clewell III - Regulatory Toxicology and …, 2003 - Elsevier
In recent years efforts have increased to develop a framework for assessing differences,
both pharmacokinetic and pharmacodynamic, between children and adults for purposes of …

Development of a novel maternal-fetal physiologically based pharmacokinetic model I: insights into factors that determine fetal drug exposure through simulations and …

Z Zhang, MZ Imperial, GI Patilea-Vrana… - Drug Metabolism and …, 2017 - ASPET
Determining fetal drug exposure (except at the time of birth) is not possible for both logistical
and ethical reasons. Therefore, we developed a novel maternal-fetal physiologically based …